nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—ABCB1—Topotecan—cervical cancer	0.193	0.625	CbGbCtD
Haloperidol—CYP3A4—Topotecan—cervical cancer	0.116	0.375	CbGbCtD
Haloperidol—H1F0—semen—cervical cancer	0.0527	0.0916	CbGeAlD
Haloperidol—EBP—uterine cervix—cervical cancer	0.0258	0.0448	CbGeAlD
Haloperidol—EBP—uterus—cervical cancer	0.0215	0.0373	CbGeAlD
Haloperidol—EBP—female reproductive system—cervical cancer	0.0193	0.0336	CbGeAlD
Haloperidol—UGT1A9—renal system—cervical cancer	0.0146	0.0254	CbGeAlD
Haloperidol—CBR1—uterine cervix—cervical cancer	0.0118	0.0204	CbGeAlD
Haloperidol—CBR1—decidua—cervical cancer	0.0112	0.0195	CbGeAlD
Haloperidol—CBR1—renal system—cervical cancer	0.011	0.0191	CbGeAlD
Haloperidol—CBR1—endometrium—cervical cancer	0.0106	0.0185	CbGeAlD
Haloperidol—CBR1—mammalian vulva—cervical cancer	0.0103	0.0179	CbGeAlD
Haloperidol—CBR1—uterus—cervical cancer	0.0098	0.017	CbGeAlD
Haloperidol—H1F0—uterine cervix—cervical cancer	0.00963	0.0167	CbGeAlD
Haloperidol—H1F0—decidua—cervical cancer	0.00918	0.0159	CbGeAlD
Haloperidol—H1F0—renal system—cervical cancer	0.00901	0.0157	CbGeAlD
Haloperidol—CBR1—female reproductive system—cervical cancer	0.00881	0.0153	CbGeAlD
Haloperidol—H1F0—endometrium—cervical cancer	0.00871	0.0151	CbGeAlD
Haloperidol—H1F0—mammalian vulva—cervical cancer	0.00843	0.0146	CbGeAlD
Haloperidol—H1F0—uterus—cervical cancer	0.00803	0.0139	CbGeAlD
Haloperidol—CBR1—female gonad—cervical cancer	0.00801	0.0139	CbGeAlD
Haloperidol—CBR1—vagina—cervical cancer	0.00797	0.0138	CbGeAlD
Haloperidol—H1F0—female reproductive system—cervical cancer	0.00722	0.0125	CbGeAlD
Haloperidol—SIGMAR1—uterine cervix—cervical cancer	0.00696	0.0121	CbGeAlD
Haloperidol—HTR2B—uterine cervix—cervical cancer	0.00694	0.0121	CbGeAlD
Haloperidol—SIGMAR1—decidua—cervical cancer	0.00663	0.0115	CbGeAlD
Haloperidol—HTR2B—decidua—cervical cancer	0.00661	0.0115	CbGeAlD
Haloperidol—H1F0—female gonad—cervical cancer	0.00657	0.0114	CbGeAlD
Haloperidol—H1F0—vagina—cervical cancer	0.00653	0.0113	CbGeAlD
Haloperidol—SIGMAR1—endometrium—cervical cancer	0.00629	0.0109	CbGeAlD
Haloperidol—HTR2B—endometrium—cervical cancer	0.00628	0.0109	CbGeAlD
Haloperidol—SIGMAR1—mammalian vulva—cervical cancer	0.00609	0.0106	CbGeAlD
Haloperidol—SIGMAR1—uterus—cervical cancer	0.0058	0.0101	CbGeAlD
Haloperidol—HTR2B—uterus—cervical cancer	0.00578	0.01	CbGeAlD
Haloperidol—HTR1B—female reproductive system—cervical cancer	0.00577	0.01	CbGeAlD
Haloperidol—HTR1D—female reproductive system—cervical cancer	0.00559	0.00971	CbGeAlD
Haloperidol—KCNH2—uterine cervix—cervical cancer	0.00554	0.00962	CbGeAlD
Haloperidol—HTR2B—female reproductive system—cervical cancer	0.0052	0.00903	CbGeAlD
Haloperidol—KCNH2—renal system—cervical cancer	0.00518	0.009	CbGeAlD
Haloperidol—CBR1—lymph node—cervical cancer	0.00515	0.00895	CbGeAlD
Haloperidol—KCNH2—endometrium—cervical cancer	0.00501	0.0087	CbGeAlD
Haloperidol—SIGMAR1—female gonad—cervical cancer	0.00474	0.00824	CbGeAlD
Haloperidol—CYP1A1—epithelium—cervical cancer	0.00472	0.00819	CbGeAlD
Haloperidol—SIGMAR1—vagina—cervical cancer	0.00471	0.00819	CbGeAlD
Haloperidol—HTR2B—vagina—cervical cancer	0.0047	0.00817	CbGeAlD
Haloperidol—CYP1A1—uterine cervix—cervical cancer	0.00468	0.00812	CbGeAlD
Haloperidol—KCNH2—uterus—cervical cancer	0.00461	0.00801	CbGeAlD
Haloperidol—CYP3A5—uterine cervix—cervical cancer	0.00457	0.00794	CbGeAlD
Haloperidol—HRH1—epithelium—cervical cancer	0.00448	0.00777	CbGeAlD
Haloperidol—HRH1—uterine cervix—cervical cancer	0.00444	0.00771	CbGeAlD
Haloperidol—CYP1A2—renal system—cervical cancer	0.00443	0.0077	CbGeAlD
Haloperidol—CYP1A1—renal system—cervical cancer	0.00437	0.0076	CbGeAlD
Haloperidol—CYP3A5—renal system—cervical cancer	0.00428	0.00743	CbGeAlD
Haloperidol—HRH1—decidua—cervical cancer	0.00423	0.00734	CbGeAlD
Haloperidol—H1F0—lymph node—cervical cancer	0.00422	0.00733	CbGeAlD
Haloperidol—KCNH2—female reproductive system—cervical cancer	0.00415	0.00721	CbGeAlD
Haloperidol—CYP1A1—mammalian vulva—cervical cancer	0.00409	0.00711	CbGeAlD
Haloperidol—HRH1—endometrium—cervical cancer	0.00401	0.00697	CbGeAlD
Haloperidol—CYP2C19—vagina—cervical cancer	0.00393	0.00683	CbGeAlD
Haloperidol—CYP1A1—uterus—cervical cancer	0.0039	0.00677	CbGeAlD
Haloperidol—HRH1—mammalian vulva—cervical cancer	0.00388	0.00674	CbGeAlD
Haloperidol—KCNH2—female gonad—cervical cancer	0.00377	0.00656	CbGeAlD
Haloperidol—KCNH2—vagina—cervical cancer	0.00375	0.00652	CbGeAlD
Haloperidol—HTR2A—epithelium—cervical cancer	0.00374	0.00649	CbGeAlD
Haloperidol—CYP1A1—female reproductive system—cervical cancer	0.0035	0.00608	CbGeAlD
Haloperidol—HTR2A—renal system—cervical cancer	0.00347	0.00602	CbGeAlD
Haloperidol—CYP2C9—female reproductive system—cervical cancer	0.00337	0.00586	CbGeAlD
Haloperidol—HRH1—female reproductive system—cervical cancer	0.00332	0.00577	CbGeAlD
Haloperidol—CYP3A4—renal system—cervical cancer	0.00321	0.00558	CbGeAlD
Haloperidol—CYP1A1—female gonad—cervical cancer	0.00319	0.00554	CbGeAlD
Haloperidol—CYP1A1—vagina—cervical cancer	0.00317	0.0055	CbGeAlD
Haloperidol—CYP2D6—renal system—cervical cancer	0.00316	0.00549	CbGeAlD
Haloperidol—CYP3A5—female gonad—cervical cancer	0.00312	0.00541	CbGeAlD
Haloperidol—CYP3A5—vagina—cervical cancer	0.0031	0.00538	CbGeAlD
Haloperidol—SIGMAR1—lymph node—cervical cancer	0.00305	0.0053	CbGeAlD
Haloperidol—HTR2B—lymph node—cervical cancer	0.00304	0.00528	CbGeAlD
Haloperidol—HRH1—female gonad—cervical cancer	0.00303	0.00525	CbGeAlD
Haloperidol—HRH1—vagina—cervical cancer	0.00301	0.00522	CbGeAlD
Haloperidol—HTR2A—female reproductive system—cervical cancer	0.00278	0.00482	CbGeAlD
Haloperidol—CYP3A4—female reproductive system—cervical cancer	0.00257	0.00447	CbGeAlD
Haloperidol—CYP2D6—female reproductive system—cervical cancer	0.00253	0.00439	CbGeAlD
Haloperidol—HTR2A—vagina—cervical cancer	0.00251	0.00436	CbGeAlD
Haloperidol—ABCB1—epithelium—cervical cancer	0.00245	0.00425	CbGeAlD
Haloperidol—ABCB1—uterine cervix—cervical cancer	0.00243	0.00422	CbGeAlD
Haloperidol—KCNH2—lymph node—cervical cancer	0.00243	0.00421	CbGeAlD
Haloperidol—ABCB1—decidua—cervical cancer	0.00231	0.00402	CbGeAlD
Haloperidol—CYP2D6—female gonad—cervical cancer	0.0023	0.004	CbGeAlD
Haloperidol—ABCB1—renal system—cervical cancer	0.00227	0.00395	CbGeAlD
Haloperidol—ABCB1—endometrium—cervical cancer	0.0022	0.00382	CbGeAlD
Haloperidol—ABCB1—mammalian vulva—cervical cancer	0.00212	0.00369	CbGeAlD
Haloperidol—CYP1A1—lymph node—cervical cancer	0.00205	0.00356	CbGeAlD
Haloperidol—ABCB1—uterus—cervical cancer	0.00202	0.00352	CbGeAlD
Haloperidol—HRH1—lymph node—cervical cancer	0.00194	0.00338	CbGeAlD
Haloperidol—ABCB1—female reproductive system—cervical cancer	0.00182	0.00316	CbGeAlD
Haloperidol—ABCB1—female gonad—cervical cancer	0.00166	0.00288	CbGeAlD
Haloperidol—ABCB1—vagina—cervical cancer	0.00165	0.00286	CbGeAlD
Haloperidol—ABCB1—lymph node—cervical cancer	0.00106	0.00185	CbGeAlD
Haloperidol—H1F0—Cellular responses to stress—STAT3—cervical cancer	0.000301	0.0026	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—TAAR6—cervical cancer	0.0003	0.0026	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—WNT2—cervical cancer	0.0003	0.0026	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000296	0.00256	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—TAAR6—cervical cancer	0.000296	0.00256	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—TAAR6—cervical cancer	0.000293	0.00254	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—TAAR6—cervical cancer	0.000289	0.0025	CbGpPWpGaD
Haloperidol—KCNH2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000289	0.0025	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—TAAR6—cervical cancer	0.000282	0.00244	CbGpPWpGaD
Haloperidol—KCNH2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000278	0.00241	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—TAAR6—cervical cancer	0.000266	0.0023	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—TAAR6—cervical cancer	0.000263	0.00227	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—HES1—cervical cancer	0.000258	0.00223	CbGpPWpGaD
Haloperidol—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00025	0.00216	CbGpPWpGaD
Haloperidol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.00025	0.00216	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—WNT2—cervical cancer	0.00024	0.00207	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—WNT2—cervical cancer	0.000235	0.00203	CbGpPWpGaD
Haloperidol—DRD2—GPCR ligand binding—WNT5A—cervical cancer	0.000232	0.00201	CbGpPWpGaD
Haloperidol—HTR1D—GPCR downstream signaling—AKAP13—cervical cancer	0.000232	0.002	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—WNT2—cervical cancer	0.000231	0.002	CbGpPWpGaD
Haloperidol—H1F0—Cellular responses to stress—TP53—cervical cancer	0.000229	0.00199	CbGpPWpGaD
Haloperidol—HTR2A—GPCR ligand binding—WNT5A—cervical cancer	0.000228	0.00197	CbGpPWpGaD
Haloperidol—HRH1—GPCR ligand binding—WNT5A—cervical cancer	0.000227	0.00197	CbGpPWpGaD
Haloperidol—HTR1B—GPCR downstream signaling—AKAP13—cervical cancer	0.000227	0.00196	CbGpPWpGaD
Haloperidol—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.000224	0.00194	CbGpPWpGaD
Haloperidol—DRD4—GPCR downstream signaling—AKAP13—cervical cancer	0.000223	0.00193	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—TAAR6—cervical cancer	0.000221	0.00192	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—WNT2—cervical cancer	0.00022	0.00191	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—TAAR6—cervical cancer	0.000218	0.00188	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—TAAR6—cervical cancer	0.000217	0.00188	CbGpPWpGaD
Haloperidol—HTR2B—GPCR downstream signaling—AKAP13—cervical cancer	0.000213	0.00184	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—AKAP13—cervical cancer	0.00021	0.00182	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—WNT2—cervical cancer	0.000208	0.0018	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—AKAP13—cervical cancer	0.000206	0.00178	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—WNT2—cervical cancer	0.000205	0.00177	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—AKAP13—cervical cancer	0.000203	0.00175	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—TAAR6—cervical cancer	0.000201	0.00174	CbGpPWpGaD
Haloperidol—DRD1—GPCR downstream signaling—AKAP13—cervical cancer	0.000201	0.00174	CbGpPWpGaD
Haloperidol—DRD3—GPCR downstream signaling—AKAP13—cervical cancer	0.000198	0.00172	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	0.000198	0.00171	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—TAAR6—cervical cancer	0.000197	0.00171	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—NOTCH1—cervical cancer	0.000195	0.00169	CbGpPWpGaD
Haloperidol—EBP—Metabolism—MTHFR—cervical cancer	0.000194	0.00168	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—AKAP13—cervical cancer	0.000193	0.00167	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—MTHFR—cervical cancer	0.000191	0.00165	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—AKAP13—cervical cancer	0.000182	0.00158	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—WNT5A—cervical cancer	0.000182	0.00157	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TAAR6—cervical cancer	0.000181	0.00157	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—AKAP13—cervical cancer	0.00018	0.00156	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—WNT5A—cervical cancer	0.000178	0.00154	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TAAR6—cervical cancer	0.000177	0.00154	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—WNT5A—cervical cancer	0.000175	0.00151	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TAAR6—cervical cancer	0.000175	0.00151	CbGpPWpGaD
Haloperidol—ABCB1—Allograft Rejection—CASP3—cervical cancer	0.00017	0.00147	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—WNT5A—cervical cancer	0.000167	0.00145	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TAAR6—cervical cancer	0.000167	0.00144	CbGpPWpGaD
Haloperidol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000159	0.00138	CbGpPWpGaD
Haloperidol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000159	0.00138	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—WNT5A—cervical cancer	0.000157	0.00136	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TAAR6—cervical cancer	0.000157	0.00136	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—WNT2—cervical cancer	0.000157	0.00136	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000156	0.00135	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—WNT5A—cervical cancer	0.000155	0.00134	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TAAR6—cervical cancer	0.000155	0.00134	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.000154	0.00134	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—WNT2—cervical cancer	0.000154	0.00133	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.000152	0.00131	CbGpPWpGaD
Haloperidol—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000151	0.00131	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000149	0.00129	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—AKAP13—cervical cancer	0.000149	0.00129	CbGpPWpGaD
Haloperidol—GRIN2B—Axon guidance—EGFR—cervical cancer	0.000144	0.00124	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—WNT2—cervical cancer	0.000142	0.00122	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CA9—cervical cancer	0.000141	0.00122	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—WNT2—cervical cancer	0.000139	0.0012	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.000138	0.00119	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—WNT2—cervical cancer	0.000136	0.00118	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.000136	0.00117	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—AKAP13—cervical cancer	0.000135	0.00117	CbGpPWpGaD
Haloperidol—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000132	0.00114	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—WNT2—cervical cancer	0.00013	0.00113	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—CTNNB1—cervical cancer	0.00013	0.00112	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AKAP13—cervical cancer	0.000124	0.00108	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—WNT2—cervical cancer	0.000123	0.00106	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—TP53—cervical cancer	0.000122	0.00106	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AKAP13—cervical cancer	0.000122	0.00105	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—WNT2—cervical cancer	0.000121	0.00105	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AKAP13—cervical cancer	0.00012	0.00104	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000119	0.00103	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CA9—cervical cancer	0.000119	0.00103	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000119	0.00103	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000117	0.00101	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000117	0.00101	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.000117	0.00101	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.000117	0.00101	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AKAP13—cervical cancer	0.000114	0.000989	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—STAT3—cervical cancer	0.000113	0.000977	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000111	0.000958	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—TP53—cervical cancer	0.00011	0.000954	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—TP53—cervical cancer	0.000109	0.000942	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AKAP13—cervical cancer	0.000108	0.000933	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—WNT5A—cervical cancer	0.000107	0.000928	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.000106	0.00092	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—WNT5A—cervical cancer	0.000105	0.000909	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—WNT5A—cervical cancer	0.000103	0.000894	CbGpPWpGaD
Haloperidol—GRIN2B—Developmental Biology—EGFR—cervical cancer	0.000103	0.000888	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—WNT5A—cervical cancer	9.86e-05	0.000854	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—WNT5A—cervical cancer	9.3e-05	0.000805	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—WNT2—cervical cancer	9.27e-05	0.000802	CbGpPWpGaD
Haloperidol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	9.24e-05	0.0008	CbGpPWpGaD
Haloperidol—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	9.22e-05	0.000798	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—WNT5A—cervical cancer	9.18e-05	0.000794	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—WNT2—cervical cancer	9.12e-05	0.000789	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—WNT2—cervical cancer	9.1e-05	0.000788	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CA9—cervical cancer	8.59e-05	0.000743	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	8.37e-05	0.000725	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—TP53—cervical cancer	8.32e-05	0.000721	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AKAP13—cervical cancer	8.14e-05	0.000704	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CA9—cervical cancer	8.11e-05	0.000702	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	8.07e-05	0.000698	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AKAP13—cervical cancer	8.01e-05	0.000693	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AKAP13—cervical cancer	7.99e-05	0.000691	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NOTCH2—cervical cancer	7.53e-05	0.000652	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NOTCH2—cervical cancer	7.37e-05	0.000638	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NOTCH2—cervical cancer	7.25e-05	0.000628	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—WNT5A—cervical cancer	7.02e-05	0.000608	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	6.92e-05	0.000599	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—WNT5A—cervical cancer	6.91e-05	0.000598	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—WNT5A—cervical cancer	6.9e-05	0.000597	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CA9—cervical cancer	6.64e-05	0.000575	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NOTCH2—cervical cancer	6.53e-05	0.000565	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CA9—cervical cancer	6.48e-05	0.000561	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NOTCH2—cervical cancer	6.44e-05	0.000558	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	6.39e-05	0.000553	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—HES1—cervical cancer	6.17e-05	0.000534	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CA9—cervical cancer	6.11e-05	0.000528	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CA9—cervical cancer	6.05e-05	0.000524	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—HES1—cervical cancer	6.04e-05	0.000523	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—HES1—cervical cancer	5.95e-05	0.000515	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—MTHFR—cervical cancer	5.73e-05	0.000496	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—HES1—cervical cancer	5.68e-05	0.000491	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TERT—cervical cancer	5.41e-05	0.000468	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	5.37e-05	0.000465	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—HES1—cervical cancer	5.35e-05	0.000463	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TERT—cervical cancer	5.3e-05	0.000458	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—HES1—cervical cancer	5.28e-05	0.000457	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TERT—cervical cancer	5.21e-05	0.000451	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CA9—cervical cancer	5.17e-05	0.000448	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TERT—cervical cancer	4.97e-05	0.000431	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—FGFR3—cervical cancer	4.96e-05	0.00043	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOTCH2—cervical cancer	4.93e-05	0.000427	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—FGFR3—cervical cancer	4.86e-05	0.000421	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	4.85e-05	0.00042	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOTCH2—cervical cancer	4.84e-05	0.000419	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—MTHFR—cervical cancer	4.82e-05	0.000417	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—FGFR3—cervical cancer	4.78e-05	0.000414	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TERT—cervical cancer	4.69e-05	0.000406	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	4.66e-05	0.000403	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TERT—cervical cancer	4.63e-05	0.000401	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—FGFR3—cervical cancer	4.56e-05	0.000395	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	4.56e-05	0.000395	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—NOTCH1—cervical cancer	4.49e-05	0.000389	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—FGFR3—cervical cancer	4.3e-05	0.000373	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	4.29e-05	0.000371	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—FGFR3—cervical cancer	4.25e-05	0.000368	CbGpPWpGaD
Haloperidol—HTR1D—Signaling by GPCR—EGFR—cervical cancer	4.15e-05	0.000359	CbGpPWpGaD
Haloperidol—HTR1B—Signaling by GPCR—EGFR—cervical cancer	4.06e-05	0.000352	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—HES1—cervical cancer	4.04e-05	0.00035	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—NOTCH1—cervical cancer	4.04e-05	0.00035	CbGpPWpGaD
Haloperidol—DRD4—Signaling by GPCR—EGFR—cervical cancer	4e-05	0.000346	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CA9—cervical cancer	3.99e-05	0.000346	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—NOTCH1—cervical cancer	3.99e-05	0.000345	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—HES1—cervical cancer	3.98e-05	0.000344	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—HES1—cervical cancer	3.97e-05	0.000343	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—EGFR—cervical cancer	3.82e-05	0.00033	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—EGFR—cervical cancer	3.6e-05	0.000312	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—EGFR—cervical cancer	3.55e-05	0.000308	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TERT—cervical cancer	3.54e-05	0.000307	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—MTOR—cervical cancer	3.49e-05	0.000302	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TERT—cervical cancer	3.48e-05	0.000302	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—MTHFR—cervical cancer	3.48e-05	0.000302	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TERT—cervical cancer	3.48e-05	0.000301	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—MTOR—cervical cancer	3.42e-05	0.000296	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—MTOR—cervical cancer	3.36e-05	0.000291	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—MTHFR—cervical cancer	3.29e-05	0.000285	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—FGFR3—cervical cancer	3.25e-05	0.000281	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—MTOR—cervical cancer	3.21e-05	0.000278	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CASP3—cervical cancer	3.21e-05	0.000278	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—FGFR3—cervical cancer	3.2e-05	0.000277	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—FGFR3—cervical cancer	3.19e-05	0.000276	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CASP3—cervical cancer	3.14e-05	0.000272	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	3.1e-05	0.000268	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CASP3—cervical cancer	3.09e-05	0.000268	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—NOTCH1—cervical cancer	3.05e-05	0.000264	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	3.03e-05	0.000262	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—MTOR—cervical cancer	3.03e-05	0.000262	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	3e-05	0.00026	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—NOTCH1—cervical cancer	3e-05	0.000259	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—MTOR—cervical cancer	2.99e-05	0.000259	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CTNNB1—cervical cancer	2.98e-05	0.000258	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CASP3—cervical cancer	2.95e-05	0.000256	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	2.85e-05	0.000246	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CASP3—cervical cancer	2.79e-05	0.000241	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CASP3—cervical cancer	2.75e-05	0.000238	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—EGFR—cervical cancer	2.72e-05	0.000235	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—STAT3—cervical cancer	2.7e-05	0.000234	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—MTHFR—cervical cancer	2.69e-05	0.000233	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CTNNB1—cervical cancer	2.68e-05	0.000232	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—EGFR—cervical cancer	2.68e-05	0.000232	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—EGFR—cervical cancer	2.67e-05	0.000231	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CTNNB1—cervical cancer	2.65e-05	0.000229	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—STAT3—cervical cancer	2.64e-05	0.000229	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—MTHFR—cervical cancer	2.63e-05	0.000228	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—STAT3—cervical cancer	2.6e-05	0.000225	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—STAT3—cervical cancer	2.48e-05	0.000215	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—MTHFR—cervical cancer	2.48e-05	0.000214	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—MTHFR—cervical cancer	2.46e-05	0.000213	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—EGFR—cervical cancer	2.45e-05	0.000212	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—EGFR—cervical cancer	2.4e-05	0.000208	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—EGFR—cervical cancer	2.36e-05	0.000205	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—STAT3—cervical cancer	2.34e-05	0.000203	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—STAT3—cervical cancer	2.31e-05	0.0002	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—MTOR—cervical cancer	2.29e-05	0.000198	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—EGFR—cervical cancer	2.26e-05	0.000195	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—MTOR—cervical cancer	2.25e-05	0.000195	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—MTOR—cervical cancer	2.24e-05	0.000194	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—EGFR—cervical cancer	2.13e-05	0.000184	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CASP3—cervical cancer	2.1e-05	0.000182	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—MTHFR—cervical cancer	2.1e-05	0.000182	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—EGFR—cervical cancer	2.1e-05	0.000182	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CASP3—cervical cancer	2.07e-05	0.000179	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CASP3—cervical cancer	2.06e-05	0.000179	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TP53—cervical cancer	2.06e-05	0.000178	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CTNNB1—cervical cancer	2.03e-05	0.000175	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TP53—cervical cancer	2.02e-05	0.000174	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	1.99e-05	0.000173	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CTNNB1—cervical cancer	1.99e-05	0.000172	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TP53—cervical cancer	1.98e-05	0.000172	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TP53—cervical cancer	1.89e-05	0.000164	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TP53—cervical cancer	1.79e-05	0.000155	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—STAT3—cervical cancer	1.77e-05	0.000153	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TP53—cervical cancer	1.76e-05	0.000153	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—STAT3—cervical cancer	1.74e-05	0.00015	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—STAT3—cervical cancer	1.73e-05	0.00015	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—MTHFR—cervical cancer	1.62e-05	0.00014	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—EGFR—cervical cancer	1.61e-05	0.000139	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—EGFR—cervical cancer	1.58e-05	0.000137	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—EGFR—cervical cancer	1.58e-05	0.000136	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TP53—cervical cancer	1.35e-05	0.000117	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TP53—cervical cancer	1.33e-05	0.000115	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TP53—cervical cancer	1.32e-05	0.000115	CbGpPWpGaD
